A Phase I Trial of GW01-200 Tablets in Subjects With Advanced Tumors
NCT07629258
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Tumors
Interventions
DRUG:
GW01-200
Sponsor
Groovy Medicine (Hangzhou) Ltd.